Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A phase II randomized controlled trial evaluating the immunogenicity and safety of a recombinant aP vaccine and various Tdap vaccine formulations in healthy women of child bearing age

Trial Profile

A phase II randomized controlled trial evaluating the immunogenicity and safety of a recombinant aP vaccine and various Tdap vaccine formulations in healthy women of child bearing age

Completed
Phase of Trial: Phase II

Latest Information Update: 22 Oct 2018

At a glance

  • Drugs DTaP vaccine (Primary) ; Pertussis acellular vaccine (Primary) ; DTaP vaccine
  • Indications Pertussis
  • Focus Pharmacodynamics
  • Sponsors BioNet-Asia
  • Most Recent Events

    • 11 Sep 2018 Status changed from recruiting to completed.
    • 20 Aug 2018 Status changed from not yet recruiting to recruiting.
    • 19 Jun 2018 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top